Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Icu Medical (ICUI) Change in Receivables (2016 - 2025)

Icu Medical (ICUI) has disclosed Change in Receivables for 17 consecutive years, with -$4.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Receivables fell 113.96% year-over-year to -$4.9 million, compared with a TTM value of -$8.9 million through Dec 2025, down 118.95%, and an annual FY2025 reading of -$8.9 million, down 118.95% over the prior year.
  • Change in Receivables was -$4.9 million for Q4 2025 at Icu Medical, down from $12.7 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $35.3 million in Q4 2024 and bottomed at -$82.0 million in Q1 2023.
  • Average Change in Receivables over 5 years is -$263550.0, with a median of $1.6 million recorded in 2021.
  • Peak annual rise in Change in Receivables hit 4222.2% in 2022, while the deepest fall reached 1393.29% in 2022.
  • Year by year, Change in Receivables stood at -$9.9 million in 2021, then soared by 202.48% to $10.2 million in 2022, then plummeted by 154.43% to -$5.5 million in 2023, then soared by 736.64% to $35.3 million in 2024, then crashed by 113.96% to -$4.9 million in 2025.
  • Business Quant data shows Change in Receivables for ICUI at -$4.9 million in Q4 2025, $12.7 million in Q3 2025, and $5.7 million in Q2 2025.